Hormones, EBV and genes: Uncovering the causes of MSÂ
22 February 2022
Australian researchers have found that estrogen may influence and interact with MS risk genes and lead to changes in response to Epstein-Barr virus (EBV).Â
Australian researchers have found that estrogen may influence and interact with MS risk genes and lead to changes in response to Epstein-Barr virus (EBV).Â
The Australian Government launched Australia’s Disability Strategy 2021-2031  on 3 December 2021. The Strategy is designed to drive change over the next decade to uphold the rights, inclusion and participation of people with disability in all areas of Australian life.
If health is a focus for you in 2022, here are six quick and easy tips from a Nutritionist, to help you get your health back on track in 2022. Â
The International Progressive MS Alliance has outlined the priorities and coordinated global efforts needed to offer better treatment and quality of life to people living with progressive MS.
CEO Rohan Greenland gives an update on the MS Australia activities, focusing on the upcoming major projects, including the announcement of our 2022 grant round.
MS Australia is delighted to announce nearly $7 million of funding towards MS research commencing in 2022 in our largest funding round to date.
Researchers have discovered how immune cell ‘spider webs’ may cause the damaging immune response seen in many immune-mediated diseases.
MS advocates Emily Petricola OAM and Paul Murnane AM have been recognised in The Australia Day Honours List for 2022.
A new study has provided the strongest evidence yet that infection with the Epstein-Barr virus (EBV), which causes glandular fever, may also cause MS.